Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;36(3):653-655.
doi: 10.1038/s41433-021-01425-0. Epub 2021 Feb 9.

The impacts of COVID-19 on glaucoma patient outcomes as assessed by POEM

Collaborators, Affiliations

The impacts of COVID-19 on glaucoma patient outcomes as assessed by POEM

Rathin Pujari et al. Eye (Lond). 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Comparison of pre-COVID patient report outcomes to those in the peri-COVID era using the POEM Item Questionnaire.
Comparison of the two graphs (A: pre-COVID, B: post-COVID) reveals that the largest decrease (at least 10%) in ‘strongly agree responses’ occurs in Q2 (patient’s understanding of their treatment for glaucoma), Q4 (progression of glaucoma), Q7 and Q8 (patient’s perception and confidence in their treatment team).
Fig. 2
Fig. 2. Patient responses identifying if COVID had caused increased concern based on each item of the POEM Questionnaire.
Domains pertaining to safety (Q7) and organizational aspects (Q8) of glaucoma treatment (both related to the perception by the patient of the treatment team) were the areas which patients explicitly identified as areas of concern due to COVID. This correlated with the results from graphs in Fig. 1 when comparing pre-COVID and post-COVID POEM results.

References

    1. Somner JEA, Sii F, Bourne RR, Cross V, Burr JM, Shah P. Moving from PROMs to POEMs for glaucoma care: a qualitative scoping exercise. Investig Ophthalmol Vis Sci. 2012;53:5940–7. doi: 10.1167/iovs.12-10223. - DOI - PubMed
    1. Fraenkel A, Lee GA, Vincent SJ, Vincent RA, Bourne RRA, Shah P. Lessons learned from the development and implementation of a patient-reported outcome and experience measure (POEM) in an Australian glaucoma practice. BMC Ophthalmol. 2019;19:192. doi: 10.1186/s12886-019-1198-7. - DOI - PMC - PubMed
    1. Foot B, MacEwen C. Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome. Eye. 2017;31:771–5. doi: 10.1038/eye.2017.1. - DOI - PMC - PubMed
    1. Jayaram H, Strouthidis NG, Gazzard G. The COVID-19 pandemic will redefine the future delivery of glaucoma care. Eye. 2020;34:1203–5. doi: 10.1038/s41433-020-0958-1. - DOI - PMC - PubMed